Inorganic polyphosphate as an energy source in tumorigenesis.

OXPHOS energy source glycolysis metabolism polyphosphate

Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
15 Dec 2020
Historique:
received: 22 08 2020
accepted: 20 11 2020
entrez: 5 1 2021
pubmed: 6 1 2021
medline: 6 1 2021
Statut: epublish

Résumé

Cancer cells have high demands for energy to maintain their exceedingly proliferative growth. However, the mechanism of energy expenditure in cancer is not well understood. We hypothesize that cancer cells might utilize energy-rich inorganic polyphosphate (polyP), as energetic reserve. PolyP is comprised of orthophosphates linked by phosphoanhydride bonds, as in ATP. Here, we show that polyP is highly abundant in several types of cancer cells, including brain tumor-initiating cells (BTICs), i.e., stem-like cells derived from a mouse brain tumor model that we have previously described. The polymer is avidly consumed during starvation of the BTICs. Depletion of ATP by inhibiting glycolysis and mitochondrial ATP-synthase (OXPHOS) further decreases the levels of polyP and alters morphology of the cells. Moreover, enzymatic hydrolysis of the polymer impairs the viability of cancer cells and significantly deprives ATP stores. These results suggest that polyP might be utilized as a source of phosphate energy in cancer. While the role of polyP as an energy source is established for bacteria, this finding is the first demonstration that polyP may play a similar role in the metabolism of cancer cells.

Identifiants

pubmed: 33400735
doi: 10.18632/oncotarget.27838
pii: 27838
pmc: PMC7747861
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4613-4624

Informations de copyright

Copyright: © 2020 Boyineni et al.

Déclaration de conflit d'intérêts

CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.

Références

Cancer Res. 1989 Dec 1;49(23):6449-65
pubmed: 2684393
Appl Environ Microbiol. 2005 Oct;71(10):5692-701
pubmed: 16204477
Mol Biol Evol. 2000 Jun;17(6):951-61
pubmed: 10833202
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16085-7
pubmed: 15520374
Semin Cancer Biol. 2017 Dec;47:18-28
pubmed: 28673608
Int J Mol Sci. 2013 May 23;14(6):10727-48
pubmed: 23702844
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18091-6
pubmed: 17986607
Front Oncol. 2019 Dec 12;9:1410
pubmed: 31921667
Curr Opin Microbiol. 2015 Apr;24:1-6
pubmed: 25589044
Curr Opin Genet Dev. 1999 Dec;9(6):678-87
pubmed: 10607615
Annu Rev Biochem. 1999;68:89-125
pubmed: 10872445
FEBS J. 2016 Jan;283(1):74-87
pubmed: 26453899
Annu Rev Nutr. 2006;26:1-22
pubmed: 16848698
Biomater Sci. 2019 Dec 1;7(12):5506-5515
pubmed: 31667480
Mol Cell. 2000 Sep;6(3):683-92
pubmed: 11030347
J Mol Biol. 2015 Apr 10;427(7):1549-63
pubmed: 25698115
J Bacteriol. 1986 Dec;168(3):1212-9
pubmed: 3782036
Biochem Soc Trans. 2020 Feb 28;48(1):95-101
pubmed: 32049314
Nat Med. 2017 Oct 6;23(10):1124-1134
pubmed: 28985214
J Biol Chem. 2010 Mar 26;285(13):9420-8
pubmed: 20124409
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11249-54
pubmed: 12970465
Gene. 2014 Jan 25;534(2):400-7
pubmed: 23954875
Oncotarget. 2018 Feb 9;9(17):13733-13747
pubmed: 29568390
PLoS One. 2015 Mar 31;10(3):e0121707
pubmed: 25826270
Annu Rev Biochem. 2009;78:605-47
pubmed: 19344251
Arch Biochem Biophys. 2019 Feb 15;662:177-189
pubmed: 30571965
EMBO Rep. 2005 Jul;6(7):681-7
pubmed: 15947782
Mayo Clin Proc. 2017 Apr;92(4):609-641
pubmed: 28385197
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12833-12838
pubmed: 31182591
Cell Calcium. 2020 Mar;86:102127
pubmed: 31954928
Tumour Biol. 2017 Jun;39(6):1010428317705033
pubmed: 28651489
J Cell Sci. 2017 Aug 15;130(16):2747-2756
pubmed: 28687622
Biochem J. 2020 Apr 30;477(8):1515-1524
pubmed: 32270854
Biochem J. 1972 Aug;128(5):1193-201
pubmed: 4643700
J Thromb Haemost. 2019 Dec;17(12):2131-2140
pubmed: 31420909
ACS Chem Biol. 2014 Sep 19;9(9):2101-10
pubmed: 25007079
J Bacteriol. 1995 Feb;177(3):491-6
pubmed: 7836277
Genome Biol. 2001;2(6):REVIEWS1018
pubmed: 11423013
Trends Biochem Sci. 2008 Jun;33(6):284-90
pubmed: 18487048
J Biol Chem. 2019 Feb 8;294(6):2180-2190
pubmed: 30425096
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16486-91
pubmed: 17940044
Mol Cell. 2014 Mar 6;53(5):689-99
pubmed: 24560923
Chem Rev. 2019 Dec 26;119(24):12337-12374
pubmed: 31738523

Auteurs

Jerusha Boyineni (J)

Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.

Simone T Sredni (ST)

Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

Naira V Margaryan (NV)

Department of Biochemistry, Robert C. Byrd Health Sciences Center and Cancer Institute, West Virginia University, Morgantown, West Virginia, USA.

Lusine Demirkhanyan (L)

Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.

Michael Tye (M)

Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.

Robert Johnson (R)

Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.

Fernando Gonzalez-Nilo (F)

Center for Bioinformatics and Integrative Biology, Universidad Andres Bello, Santiago, Chile.
Centro Interdisciplinario de Neurociencia de Valparaíso, Facultad de Ciencias, Universidad de Valparaíso, Valparaíso, Chile.

Mary J C Hendrix (MJC)

Department of Biology, Shepherd University, Shepherdstown, West Virginia, USA.

Evgeny Pavlov (E)

Department of Molecular Pathobiology, New York University, College of Dentistry, New York, New York, USA.

Marcelo B Soares (MB)

Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.

Eleonora Zakharian (E)

Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
These authors contributed equally to this work.

Sergey Malchenko (S)

Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
These authors contributed equally to this work.

Classifications MeSH